TMS Co., Ltd. (TYO:4891)

Japan flag Japan · Delayed Price · Currency is JPY
142.00
+2.00 (1.43%)
Apr 17, 2026, 3:30 PM JST
Market Cap6.46B -3.5%
Revenue (ttm)n/a
Net Income-700.90M
EPS-15.99
Shares Out45.49M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume177,800
Average Volume174,210
Open139.00
Previous Close140.00
Day's Range139.00 - 144.00
52-Week Range122.00 - 185.00
Beta0.45
RSI50.69
Earnings DateApr 17, 2026

About TMS Co., Ltd.

TMS Co., Ltd. engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities. The company is developing TMS-007, a stachybotrys microspora triprenyl phenol (SMTP) congener with prothrombolytic and anti-inflammatory/antioxidative activities, which has completed Phase 2a clinical trials for acute ischemic stroke treatment; and TMS-008, an SMTP congener with anti-inflammatory/antioxidative activities under nonclinical development for inflammatory complications... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2005
Employees 18
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4891
Full Company Profile

Financial Performance

Financial Statements